ALLAYNA TYREE: Open Payments
NPI 1376224030 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $384 |
| Astellas Pharma US Inc | 2 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Amgen Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: AIRSUPRA, SAPHNELO, Veozah, Kerendia, OTEZLA, MOUNJARO, CAPLYTA, TRELEGY ELLIPTA.
Industry payments across MT — which companies pay providers there.
